Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The objective of this study is to evaluate clinical effectiveness and the effect on quality of life of an inelastic thoracolumbarasacral orthosis in male and female hyperkyphotic patients with moderate to severe back pain disability and to demonstrate the safety of the intervention through detailed reporting and analysis of adverse events.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Group A | Active Comparator | Patients assigned to group A wore the Summit 456 TLSO (intervention) for four weeks in phase 1 of the study, followed by four weeks of observation (control) in phase 2. |
|
| Group B | Placebo Comparator | Patients assigned to group B started four weeks of observation (control) in phase 1, followed by four weeks of summit 456 TLSO (intervention) in phase 2 of the study. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Summit 456 TLSO | Other | Thoracolumbarsacral orthosis |
|
| Measure | Description | Time Frame |
|---|---|---|
| Mean difference in the Oswestry Disability Index Scores of the intervention versus control groups | 4 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Measured amount of opioid medication consumed in the intervention group versus control group | Baseline and weeks 2,3,4,8,12,16,20 and 24 |
| Measure | Description | Time Frame |
|---|---|---|
| ODI scores between the intervention group versus control group | Weeks 8, 12, 16, 20 and 24 | |
| SF-26v2 Survey scores in the intervention versus the control group | Baseline and weeks 4, 8, 12 and 24. | |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Daniel J Schaffer, MD | Southeastern Integrated Medical | Principal Investigator |
Not provided
Not provided
| ID | Term |
|---|---|
| D007738 | Kyphosis |
| D001416 | Back Pain |
| ID | Term |
|---|---|
| D013121 | Spinal Curvatures |
| D013122 | Spinal Diseases |
| D001847 | Bone Diseases |
| D009140 | Musculoskeletal Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Cost and return on investment of the LSO intervention |
| 24 weeks |
| Number of adverse events associated with the LSO intervention | Baseline and weeks 2, 3, 4, 8, 12, 16, 20 and 24 |
| D010146 |
| Pain |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |